These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35124120)

  • 1. Kinetic solubility improvement and influence of polymers on controlled supersaturation of itraconazole-succinic acid nano-co-crystals.
    Huang Z; Staufenbiel S; Bodmeier R
    Int J Pharm; 2022 Mar; 616():121536. PubMed ID: 35124120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of itraconazole nano-co-crystals into multiparticulate oral dosage forms.
    Huang Z; Staufenbiel S; Bodmeier R
    Eur J Pharm Biopharm; 2022 Jul; 176():75-86. PubMed ID: 35598769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of co-crystal and nanocrystal techniques to improve the solubility and dissolution rate of poorly soluble drugs.
    Huang Z; Staufenbiel S; Bodmeier R
    Pharm Res; 2022 May; 39(5):949-961. PubMed ID: 35552985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Extent of Supersaturation on the Evolution of Kinetic Solubility Profiles.
    Han YR; Lee PI
    Mol Pharm; 2017 Jan; 14(1):206-220. PubMed ID: 28043130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of precipitation inhibitory potential of polymers from amorphous solid dispersions.
    Chavan RB; Lodagekar A; Shastri NR
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1933-1941. PubMed ID: 30102080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot-melt extrusion for enhanced delivery of drug particles.
    Miller DA; McConville JT; Yang W; Williams RO; McGinity JW
    J Pharm Sci; 2007 Feb; 96(2):361-76. PubMed ID: 17075869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ternary Amorphous Solid Dispersions Containing a High-Viscosity Polymer and Mesoporous Silica Enhance Dissolution Performance†.
    Hanada M; Jermain SV; Thompson SA; Furuta H; Fukuda M; Williams RO
    Mol Pharm; 2021 Jan; 18(1):198-213. PubMed ID: 33291881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of Polymer/Surfactant Interactions and Their Impact on Itraconazole Solubility and Precipitation Kinetics for Developing Spray-Dried Amorphous Solid Dispersions.
    Deshpande TM; Shi H; Pietryka J; Hoag SW; Medek A
    Mol Pharm; 2018 Mar; 15(3):962-974. PubMed ID: 29345955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.
    Schver GCRM; Lee PI
    Mol Pharm; 2018 May; 15(5):2017-2026. PubMed ID: 29601723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Cellulosic Polymer's Variables on Dissolution/Solubility of Amorphous Felodipine and Crystallization Inhibition from a Supersaturated State.
    Shi NQ; Jin Y; Zhang Y; Che XX; Xiao X; Cui GH; Chen YZ; Feng B; Li ZQ; Qi XR
    AAPS PharmSciTech; 2018 Dec; 20(1):12. PubMed ID: 30560388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
    Sun DD; Lee PI
    Mol Pharm; 2015 Apr; 12(4):1203-15. PubMed ID: 25775257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of induction methods for supersaturation: Amorphous dissolution versus solvent shift.
    Plum J; Bavnhøj CG; Eliasen JN; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2020 Jul; 152():35-43. PubMed ID: 32376371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer⁻Surfactant System Based Amorphous Solid Dispersion: Precipitation Inhibition and Bioavailability Enhancement of Itraconazole.
    Feng D; Peng T; Huang Z; Singh V; Shi Y; Wen T; Lu M; Quan G; Pan X; Wu C
    Pharmaceutics; 2018 Apr; 10(2):. PubMed ID: 29695136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of supersaturation of amorphous pharmaceuticals: the effect of rate of supersaturation generation.
    Sun DD; Lee PI
    Mol Pharm; 2013 Nov; 10(11):4330-46. PubMed ID: 24066837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Grades of HPMCAS Spray Dried Dispersions of Itraconazole Based on Supersaturation Kinetics and Molecular Interactions Impacting Formulation Performance.
    Adhikari A; Polli JE
    Pharm Res; 2020 Sep; 37(10):192. PubMed ID: 32914239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5.
    Janssens S; de Armas HN; Roberts CJ; Van den Mooter G
    J Pharm Sci; 2008 Jun; 97(6):2110-20. PubMed ID: 17847067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailoring supersaturation from amorphous solid dispersions.
    Li N; Taylor LS
    J Control Release; 2018 Jun; 279():114-125. PubMed ID: 29654798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amorphization strategy affects the stability and supersaturation profile of amorphous drug nanoparticles.
    Cheow WS; Kiew TY; Yang Y; Hadinoto K
    Mol Pharm; 2014 May; 11(5):1611-20. PubMed ID: 24669821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supersaturation in human gastric fluids.
    Bevernage J; Hens B; Brouwers J; Tack J; Annaert P; Augustijns P
    Eur J Pharm Biopharm; 2012 May; 81(1):184-9. PubMed ID: 22342777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.